Stephen Shalansky
Overview
Explore the profile of Stephen Shalansky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
4.
Damji S, Legal M, Dahri K, Partovi N, Shalansky S
Can J Hosp Pharm
. 2024 Jan;
77(1):e3437.
PMID: 38204503
Background: The expanding scope of practice of hospital pharmacists has contributed to improvements in patient care; however, workload remains a barrier to the provision of optimal pharmaceutical care. Established ratios...
5.
Parmar R, Legal M, Dahri K, Wilbur K, Shalansky S, Partovi N
Can J Hosp Pharm
. 2023 Sep;
76(4):302-308.
PMID: 37767392
Background: Clinical Pharmacist Practitioners (CPPs) are independent care providers who practise to their full scope and have a positive impact on the quality of patient care. Ideally, all pharmacists in...
6.
Cameron T, Chua D, Shalansky S, Tam E, Wang E
Can J Hosp Pharm
. 2023 Jan;
76(1):23-28.
PMID: 36683662
Background: Unfractionated heparin (UFH) is used for the prevention and treatment of arterial or venous thromboembolism. The dosage for IV infusion of UFH is generally based on the patient's weight,...
7.
Ti L, Mihic T, James H, Shalansky S, Legal M, Nolan S
Can J Hosp Pharm
. 2022 Apr;
75(2):113-117.
PMID: 35387376
No abstract available.
8.
Chen A, Legal M, Shalansky S, Mihic T, Su V
Can J Hosp Pharm
. 2021 Jul;
74(3):248-255.
PMID: 34248165
Background: Deaths due to overdose from illicit drugs have risen in Canada, despite various community-led harm reduction programs. There have been limited pharmacist-led inpatient initiatives aimed at reducing opioid harm....
9.
10.